Gedeon Richter PLC
RGEDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.09B
Close$
$48.34
24.7% upside
Current Fair Value
24.7% upsideUndervalued by 24.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.09 Billion |
|---|---|
| Enterprise Value | $-230,839,624,060.00 |
| Annual dividend | $2.15 |
| Dividend yield | 5.06% |
| Earnings per Share | $1263.79 |
| Beta | 0.34 |
| Outstanding Shares | 183,075,000 |
Return
| Return on Equity | 15.74% |
|---|---|
| Return on Assets | 13.03% |
| Return on Invested Capital | 18.30% |
Valuation & Multiples
| P/E Ratio | 10.31 |
|---|---|
| PEG | -245.82 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 2.3 |
| Enterprise Value to EBIT | 7.36 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$753.95 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$741.65 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Gedeon Richter PLC
11,955 employees
CEO: Gabor Orban
Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segmen...